Further practical experiences in the recognition and management of carcinoma in situ of the testis
- PMID: 1374974
- DOI: 10.1159/000282322
Further practical experiences in the recognition and management of carcinoma in situ of the testis
Abstract
99 biopsies from the contralateral testis in patients with unilateral germ cell tumor were investigated using the semithin section technique. Four cases (4%) revealed a carcinoma in situ (CIS) pattern. Two patients underwent a local radiation (20 Gy), 2 patients received combination chemotherapy (cisplatin, etoposide and bleomycin; PEB). No tumor cells were found in control biopsies 4-8 months after therapy. Both biopsy specimens taken from radiated patients lacked also germ cells. In contrast, 1 patient who was treated with PEB and also another 1 presenting with a teratocarcinoma of apparently retroperitoneal origin and unilateral CIS revealed germ cells after chemotherapy. The present data suggest radiation therapy to be the first line treatment for CIS-bearing testes. In order to get informations about the distribution of CIS cells in the affected testes, one or two biopsies were additionally taken from macroscopically unsuspicious tissue surrounding various solid germ cell tumors (74 patients). 56 cases (76%) revealed CIS. Even considering the possibility of missing CIS, a screening biopsy is actually the only method for detecting early manifestations of germ cell tumors and should be performed routinely in contralateral testes of patients with germ cell tumors.
Similar articles
-
Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.Andrology. 2015 Jan;3(1):92-8. doi: 10.1111/j.2047-2927.2014.00260.x. Epub 2014 Aug 22. Andrology. 2015. PMID: 25146646 Review.
-
Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.Strahlenther Onkol. 2006 May;182(5):289-92. doi: 10.1007/s00066-006-1516-x. Strahlenther Onkol. 2006. PMID: 16673063
-
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.APMIS. 2003 Jan;111(1):86-91; discussion 91-2. doi: 10.1034/j.1600-0463.2003.11101121.x. APMIS. 2003. PMID: 12752243
-
Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?Acta Oncol. 2005;44(6):523-5. doi: 10.1080/02841860500251562. Acta Oncol. 2005. PMID: 16165909 No abstract available.
-
Treatment options for carcinoma in situ testis.Int J Androl. 2011 Aug;34(4 Pt 2):e32-6. doi: 10.1111/j.1365-2605.2011.01178.x. Epub 2011 Jun 9. Int J Androl. 2011. PMID: 21651575 Review.
Cited by
-
[Testicular intraepithelial neoplasms (TIN). An indication for radiotherapy?].Strahlenther Onkol. 1998 Apr;174(4):173-7. doi: 10.1007/BF03038522. Strahlenther Onkol. 1998. PMID: 9581176 Review. German.
-
Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group.Br J Cancer. 2003 Mar 24;88(6):828-31. doi: 10.1038/sj.bjc.6600771. Br J Cancer. 2003. PMID: 12644817 Free PMC article. Clinical Trial.
-
Microinvasive germ cell tumor of the testis.Virchows Arch. 2005 Sep;447(3):610-25. doi: 10.1007/s00428-005-1257-8. Epub 2005 Jun 21. Virchows Arch. 2005. PMID: 15968545 Review.
-
Current concepts of radiation treatment of carcinoma in situ of the testis.World J Urol. 1994;12(3):125-30. doi: 10.1007/BF00192268. World J Urol. 1994. PMID: 7951337 Review.
-
Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ.Strahlenther Onkol. 2023 Mar;199(3):322-326. doi: 10.1007/s00066-022-02025-x. Epub 2022 Nov 28. Strahlenther Onkol. 2023. PMID: 36441172
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical